Guidelines and Training
Cross-source consensus on Guidelines and Training from 1 sources and 4 claims.
1 sources · 4 claims
Evidence quality
Other
Other
Highlighted claims
- PERKENI guidelines provide broad T2D treatment recommendations but do not specify deprescribing timing, methods, or medicine selection. — Healthcare professionals’ barriers and enablers concerning deprescribing in type 2 diabetes patients with polypharmacy: a focus group study
- The absence of structured deprescribing guidance was described as a major barrier. — Healthcare professionals’ barriers and enablers concerning deprescribing in type 2 diabetes patients with polypharmacy: a focus group study
- General practitioners and pharmacists reported no specific deprescribing education from government, hospitals, or other institutions. — Healthcare professionals’ barriers and enablers concerning deprescribing in type 2 diabetes patients with polypharmacy: a focus group study
- The study concluded that Indonesia needs local deprescribing guidelines with protocols, decision frameworks, monitoring guidance, and follow-up strategies. — Healthcare professionals’ barriers and enablers concerning deprescribing in type 2 diabetes patients with polypharmacy: a focus group study